A woman with an extremely rare genetic disease took it upon herself to initiate the development of a drug, and became its first human trial participant, so that her sons and others with the same condition might have a better future
A rare and complex heart condition was treated with a hybrid procedure—combining open surgery and advanced endovascular technology